182 related articles for article (PubMed ID: 18680136)
1. Selectivity of neutral/weakly basic P1 group inhibitors of thrombin and trypsin by a molecular dynamics study.
Wu EL; Han K; Zhang JZ
Chemistry; 2008; 14(28):8704-14. PubMed ID: 18680136
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors.
Yan C; Xiu Z; Li X; Li S; Hao C; Teng H
Proteins; 2008 Oct; 73(1):134-49. PubMed ID: 18398905
[TBL] [Abstract][Full Text] [Related]
3. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
Fang L; Zhang H; Cui W; Ji M
J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
Lepsík M; Kríz Z; Havlas Z
Proteins; 2004 Nov; 57(2):279-93. PubMed ID: 15340915
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulations of 2-amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: interaction modes and binding free energies.
Hu R; Barbault F; Maurel F; Delamar M; Zhang R
Chem Biol Drug Des; 2010 Dec; 76(6):518-26. PubMed ID: 20942836
[TBL] [Abstract][Full Text] [Related]
6. A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.
Rizzo RC; Toba S; Kuntz ID
J Med Chem; 2004 Jun; 47(12):3065-74. PubMed ID: 15163188
[TBL] [Abstract][Full Text] [Related]
7. Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series.
Checa A; Ortiz AR; de Pascual-Teresa B; Gago F
J Med Chem; 1997 Dec; 40(25):4136-45. PubMed ID: 9406602
[TBL] [Abstract][Full Text] [Related]
8. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of new NAPAP-analogs.
Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
[TBL] [Abstract][Full Text] [Related]
10. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.
Zoete V; Michielin O
Proteins; 2007 Jun; 67(4):1026-47. PubMed ID: 17377991
[TBL] [Abstract][Full Text] [Related]
11. Free energy calculations show that acidic P1 variants undergo large pKa shifts upon binding to trypsin.
Brandsdal BO; Smalås AO; Aqvist J
Proteins; 2006 Aug; 64(3):740-8. PubMed ID: 16752417
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin.
Jiang H; Chen K; Tang Y; Chen J; Li Q; Wang Q; Ji R
J Med Chem; 1997 Sep; 40(19):3085-90. PubMed ID: 9301672
[TBL] [Abstract][Full Text] [Related]
13. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
14. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
Mlinsek G; Novic M; Kotnik M; Solmajer T
J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of binding of P1 variants to trypsin.
Brandsdal BO; Aqvist J; Smalås AO
Protein Sci; 2001 Aug; 10(8):1584-95. PubMed ID: 11468355
[TBL] [Abstract][Full Text] [Related]
16. Computational alanine scanning and free energy decomposition for E. coli type I signal peptidase with lipopeptide inhibitor complex.
Li T; Froeyen M; Herdewijn P
J Mol Graph Model; 2008 Jan; 26(5):813-23. PubMed ID: 17532654
[TBL] [Abstract][Full Text] [Related]
17. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
18. Incorporating receptor flexibility in the molecular design of protein interfaces.
Li L; Liang S; Pilcher MM; Meroueh SO
Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
[TBL] [Abstract][Full Text] [Related]
20. Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.
Strockbine B; Rizzo RC
Proteins; 2007 May; 67(3):630-42. PubMed ID: 17335007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
